NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 1, 2026 — Aquinas Senior Living expands Teton's AI monitoring across Pennsylvania, achieving 99.8% resident adoption. Learn how proactive fall detection and E-call integration are transforming senior care.
May 1, 2026 — Alpha Dental Spa in Cinnaminson, NJ celebrates 30 years of family dentistry, offering same-day emergency care, pediatric services, and cosmetic treatments for all ages.
April 30, 2026 — BioStem Technologies (BSEM) announces Q1 2026 financial results release on May 14, 2026, with a conference call and webcast at 4:30 PM ET. Learn about the company's regenerative medicine allografts and growth.
April 30, 2026 — BioVersys AG shareholders approve all board proposals at AGM, including re-election of Chairman and election of new board member. Company advances Phase 3 trial for BV100 and Phase 2 alpibectir for MDR infections.
April 30, 2026 — HeartBeam (NASDAQ: BEAT) announces May 13 conference call to discuss Q1 2026 results, arrhythmia assessment launch, and AI programs. Learn about its 3D ECG technology FDA clearance.
April 30, 2026 — Cardio Diagnostics Holdings (CDIO) leverages AI and epigenetic biomarkers to transform cardiovascular diagnostics. Learn how this precision medicine platform personalizes risk assessment from a simple blood test.
April 30, 2026 — House hearing scrutinizes hospital facility fees; GOP accuses CEOs of overcharging. Insurers like Astiva Health face implications. BioMedWire reports.
April 30, 2026 — Telomir Pharmaceuticals receives FDA clearance for Telomir-Zn IND to treat triple-negative breast cancer, initiating Phase 1/2 trial. Learn more about this biotech milestone.
April 30, 2026 — Oncotelic Therapeutics reports progress on AI and robotics platform with 28 million scientific abstracts, nearing commercial deployment for pharmaceutical development.
April 30, 2026 — HeartBeam (NASDAQ: BEAT) announces Q1 2026 conference call and updates on commercial launch of 3D ECG technology for arrhythmia assessment and heart attack detection.
April 30, 2026 — NeuroOne Medical Technologies announces CFO succession: Ron McClurg retires; Chris Volker, CFA, appointed permanent CFO. Learn about the leadership transition and NeuroOne's FDA-cleared electrode technologies.
April 30, 2026 — BioStem Technologies appoints Katherine Gorrell as Chief Legal & Compliance Officer to strengthen governance and compliance ahead of Nasdaq uplisting. Learn about her role in regenerative medicine.
April 30, 2026 — Aclarion reports 196% growth in Nociscan scans, AI patent, and U.K. reimbursement. Learn how this tech could revolutionize chronic low back pain diagnosis.
April 30, 2026 — FastBlast launches Banana Berry Smoothie Pouches on OneLavi: USDA organic, no added sugar, gluten-free. Perfect for intermittent fasting and on-the-go nutrition.
April 30, 2026 — American Heart Association warns health care affordability is a crisis, outlines five principles to fix rising costs, medical debt, and access to care.
April 29, 2026 — Earth Science Tech (ETST) builds integrated healthcare ecosystem with telemedicine, compounding pharmacies, and clinical services. Learn about their strategy for precision medicine and vertical integration.
April 29, 2026 — Learn how the American Heart Association says high blood pressure can be prevented and managed with lifestyle changes and proper monitoring. Essential tips inside.
April 29, 2026 — Regeneris introduces Flexlift™, an innovative office-based face and neck lift by Dr. Edwin Ishoo. Performed under local anesthesia, it offers natural results with minimal downtime. Learn more about this affordable alternative to traditional facelift surgery.
April 29, 2026 — Asia Summit on Global Health and Medical Fair in Hong Kong unite global healthcare leaders, featuring Nobel laureates, AI innovations, and investment opportunities. Discover breakthroughs in medtech, gerontechnology, and traditional Chinese medicine.
April 29, 2026 — Tonix Pharmaceuticals announces Phase 1 data for TNX-4800, a monoclonal antibody for Lyme disease prevention, with Phase 2 study planned for 2027. Learn about this potential breakthrough.